魏来而于2026年8月12日在联交所场内买入春雨医疗股份5300.00万股,属场内主动交易,即在二级市场直接买卖股份。
魏来而此次增持前持有春雨医疗好仓0股,占比0%;增持后持股量为5300.00万股,好仓比例升至1.6%。
魏来而于2026年8月12日在联交所场内买入春雨医疗股份5300.00万股,属场内主动交易,即在二级市场直接买卖股份。
魏来而此次增持前持有春雨医疗好仓0股,占比0%;增持后持股量为5300.00万股,好仓比例升至1.6%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.